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Expressing a cytosolic pyruvate 
dehydrogenase complex to increase free fatty 
acid production in Saccharomyces cerevisiae
Yiming Zhang1†, Mo Su1†, Ning Qin1, Jens Nielsen1,2,3 and Zihe Liu1* 
Abstract 
Background: Saccharomyces cerevisiae is being exploited as a cell factory to produce fatty acids and their derivatives 
as biofuels. Previous studies found that both precursor supply and fatty acid metabolism deregulation are essential for 
enhanced fatty acid synthesis. A bacterial pyruvate dehydrogenase (PDH) complex expressed in the yeast cytosol was 
reported to enable production of cytosolic acetyl-CoA with lower energy cost and no toxic intermediate.
Results: Overexpression of the PDH complex significantly increased cell growth, ethanol consumption and reduced 
glycerol accumulation. Furthermore, to optimize the redox imbalance in production of fatty acids from glucose, 
two endogenous  NAD+-dependent glycerol-3-phosphate dehydrogenases were deleted, and a heterologous 
 NADP+-dependent glyceraldehyde-3-phosphate dehydrogenase was introduced. The best fatty acid producing strain 
PDH7 with engineering of precursor and co-factor metabolism could produce 840.5 mg/L free fatty acids (FFAs) in 
shake flask, which was 83.2% higher than the control strain YJZ08. Profile analysis of free fatty acid suggested the cyto-
solic PDH complex mainly resulted in the increases of unsaturated fatty acids (C16:1 and C18:1).
Conclusions: We demonstrated that cytosolic PDH pathway enabled more efficient acetyl-CoA provision with the 
lower ATP cost, and improved FFA production. Together with engineering of the redox factor rebalance, the cyto-
solic PDH pathway could achieve high level of FFA production at similar levels of other best acetyl-CoA producing 
pathways.
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Background
Bioproduction of fatty acids and their derivatives serves 
as a sustainable route to alleviate the dilemma between 
the growing demands of high-energy–density fuels and 
concerns on their environmental impacts. However, fatty 
acids are involved in several essential cellular processes, 
such as membrane synthesis, energy storage, and protein 
modification, and their levels are therefore tightly regu-
lated to ensure in vivo homeostasis [1]. Intensive efforts 
have been carried out to improve the titer, rate and yield 
(TRY) of fatty acid-derived biofuels, focusing mainly on 
the deregulation of fatty acid metabolism and redirection 
of carbon flux [2–4].
Regarding deregulation of fatty acid metabolism, dele-
tions of dominant acyl-CoA synthetases (FAA1, FAA4), 
and fatty acyl-CoA oxidase (POX1) catalyzing the first 
step in β-oxidation, could significantly accumulate free 
fatty acids (FFAs) [5–7]. Moreover, deletions of main 
sterol ester formation genes (ARE1, ARE2), and phos-
phatidate phosphatase genes (PAH1, DPP1, LPP1) could 
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production of total fatty acids [8]. Combining deletion of 
several lipid regulation mechanisms resulted in a reduced 
complexity of the fatty acid metabolic network, leading to 
enhanced FFA accumulation [8, 9].
Besides engineering lipid metabolic network, engineer-
ing of precursor supply and redox cofactor regeneration 
was also essential for carbon flux redirection towards 
FFA production. Each elongation cycle in fatty acid syn-
thesis extends the backbone with a C2 unit and requires 2 
molecules of NADPH as cofactor. Endogenous synthesis 
of cytosolic acetyl-CoA, the main C2 metabolite, is often 
limited and several heterologous enzymes have therefore 
been expressed to increase acetyl-CoA supply for FFA 
synthesis, including  NAD+-dependent alcohol dehydro-
genase (AdhE),  NAD+-dependent acylating acetaldehyde 
dehydrogenase (EutE) [10], ATP citrate lyases (ACLs) [6, 
7, 11–13], xylulose-5-phosphate phosphoketolase (XpkA) 
and phosphotransacetylase (Pta) [14]. Compared to these 
strategies, expression of cytosolic pyruvate dehydro-
genase (PDH) is attractive because of its lower energy 
cost [15]. The PDH complex consists of three catalytic 
subunits, including pyruvate dehydrogenase (E1), dihy-
drolipoyl transacetylase (E2), and dihydrolipoyl dehy-
drogenase (E3), and requires four kinds of cofactors TPP, 
lipoate, FAD and  NAD+. Among three PDH complexes 
that have been expressed in the cytosol of yeast, PDH 
from Enterococcus faecalis was demonstrated to enable 
complete replacement of the native pathway for cyto-
solic acetyl-CoA synthesis, and was less sensitive to high 
NADH/NAD+ ratios compared with other PDH com-
plexes [16–18]. However, one concern with PDH expres-
sion for FFA production is the redox imbalance between 
redox couples of  NAD+/NADH and  NADP+/NADPH.
Previous studies showed that high glycerol produc-
tion was often observed in FFA production strains, indi-
cating a high NADH pressure [7]. Glycerol synthesis 
from dihydroxyacetone phosphate consists of two steps, 
catalyzed by  NAD+-dependent glycerol-3-phosphate 
dehydrogenase (encoded by GPD1 and GPD2) and glyc-
erol-3-phosphate phosphatase (encoded by GPP1 and 
GPP2), respectively (Fig. 1). Glycerol accumulation is also 
an issue in bioethanol production and has therefore been 
studied for years. Several studies found that glycerol for-
mation could be decreased with altered redox-cofactor 
specificity [11, 19–22], and could be eliminated through 
inactivation of both GPD1 and GPD2 with the expense 
of a dramatic reduction in cell growth [23]. As alterna-
tives, an  NADP+-dependent glyceraldehyde-3-phosphate 
dehydrogenase (GapN) was demonstrated to enable res-
cuing the negative effects and improve ethanol yield [24, 
25]. Moreover, since GapN irreversibly converts glycer-
aldehyde-3-phosphate to 3-phosphoglycerate and pro-
duces NADPH (Fig.  1), it was reported to increase the 
synthesis of NADPH demanding bioproducts, including 
3-hydroxypropionic acid (3-HP) and polyhydroxybu-
tyrate (PHB) [26, 27]. Therefore, it could potentially elim-
inate glycerol accumulation and increase FFA production 
by interruption of glycerol synthesis and expression of 
GapN.
The goal of this study is to investigate the effect of 
expressing the cytosolic PDH complex on FFA produc-
tion in yeast strains with deregulated fatty acid metabo-
lism and optimized cytosolic redox balance (Fig. 1). The 
strategies reported here may shed lights for production 






































Fig. 1 Schematic representation of engineering strategies for FFA production in S. cerevisiae. G3P glyceraldehyde-3-phosphate, 3PG 
3-phospho-glycerate, cPDH cytosolic pyruvate dehydrogenase. A cytosolic PDH complex was evaluated in a faa1Δ faa4Δ pox1Δ hfd1Δ mutant YJZ08 
for free fatty acid production, in combination with fatty acid metabolism engineering via pah1Δ lpp1Δ dpp1Δ are1Δ and redox cofactor engineering 
via GPD deletion and GapN expression
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Results and discussion
Expression of a bacterial PDH complex to increase 
the acetyl‑CoA supply
A FFA producing strain YJZ08 with four gene deletions 
(faa1Δ faa4Δ pox1Δ hfd1Δ) was used as the background 
strain for cytosolic PDH evaluation [6]. The three subu-
nits of PDH complex, encoded by pdhA, pdhB, aceF and 
lpd, and lipoate ligases from E. faecalis, encoded by lplA 
and lplA2 [16], were integrated into the two genome sites 
Chr XII-5 and Chr XI-3 [28] of, yielding strain PDH1. 
As shown in Fig. 2, YJZ08 with deregulated FA synthesis 
produced FFA at 458.9 mg/L in 72 h in minimal medium 
with 20  g/L glucose, which was consistent with previ-
ous studies [6, 9]. Meanwhile, the constructed strain 
PDH1 produced 512.7 mg/L FFA at 72 h (Fig. 2A) with a 
lower ethanol yield (Additional file: Table S1). From the 
growth data, we found that E. faecalis PDH reduced the 
maximum specific growth rate from 0.33 h−1 to 0.28 h−1 
but didn’t result in much difference in the final biomass. 
PDH1 accumulated 1.90  g/L glycerol, compared with 
1.90  g/L glycerol with YJZ08 (Fig.  2a), suggesting that 
cytosolic PDH did not cause an NADH burden in YJZ08.
Theoretically, a combination of the PDH route with 
the phosphoketolase (PK) pathway can result in a higher 
maximum FFA yield [15], since the PDH route could 
produce acetyl-CoA with low energy cost and the PK 
pathway could produce acetyl-CoA with low carbon 
loss. Moreover, the PK pathway utilizes xylulose-5-phos-
phate from the pentose phosphate (PP) pathway as the 
substrate, and it may thermodynamically help to pull 
the carbon flux towards the PP pathway and increase 
NADPH generation. However, we tested the integration 
of xylulose-5-phosphate phosphoketolase from Leucon-
ostoc mesenteroides [29] and phosphotransacetylase from 
Clostridium kluyveri [30] into both YJZ08 and PDH1, 
and did not find significant improvement in cell growth 
and FFA synthesis (Additional file 1: Figure S1), probably 
because of the strict control of carbon flux through the 
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Fig. 2 The expression of PDH improved FFA production in yeast with simplified lipid networks. a FFA production with expression of PDH complex 
in YJZ08. b Growth profile with expression of PDH complex in ZS01. c Growth assay of engineered strains with and without cytoplastic PDH in 
glucose medium. d Distribution of saturated and unsaturated FFAs (C16 and C18) in engineered strains. Statistical analysis was performed using 
one-tailed Student’s t-test (*p < 0.05). All data represent the mean ± SD of biological triplicates
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Moreover, the yeast ZS01 strain with simplified lipid 
metabolic networks and redirected flux towards FFA syn-
thesis was constructed by deletion of PAH1, DPP1, LPP1 
and ARE1 in YJZ08. Then, the genes encoding the PDH 
complex, composing of pdhA, pdhB, aceF, lpd, lplA and 
lplA2, were integrated into the chromosome of ZS01, 
yielding strain PDH2. As shown in Fig. 2, when cultivated 
in minimal medium with 20 g/L glucose, ZS01 accumu-
lated 497.9  mg/L FFAs at 72  h with a high productivity 
of 133.7  mg/L/OD, which was consistent with previous 
studies [8, 9]. After 72 h, ZS01 accumulated more FFAs 
since there was ethanol remaining and the FFA titer 
reached 734.2 mg/L at 144 h when ethanol was exhausted 
(Fig. 2a). Interestingly, PDH2 produced 660.2 mg/L FFAs 
at 72 h and 756.3 mg/L FFAs at 96 h when ethanol was 
completely exhausted. In PDH2, the faster FFA produc-
tion rate accompanied with a faster ethanol consumption 
rate and lower glycerol level, indicating that cytosolic 
PDH may alleviate NADH burden and speed up cell 
growth and FFA production (Fig. 2b), probably due to the 
lower energy cost.
To address the possible mismatch between acetyl-
CoA supply, NADH production and NADPH consump-
tion for FFA synthesis, we evaluated whether PDH from 
E. faecalis might utilize  NADP+ as well as  NAD+ as 
redox cofactors in a zwf1Δ ald6Δ mutant, which hardly 
grew on glucose medium due to lack of ability to pro-
duce cytosolic NADPH [32]. The results showed that 
cytosolic PDH expression could not rescue cell growth 
of the zwf1Δ ald6Δ mutant on glucose (Fig.  2c). A pre-
vious study showed that cofactor specificity of E. coli 
PDH could be converted from  NAD+ to  NADP+ via 
seven amino acid mutations in E3 [33, 34]. The align-
ment result of E3 proteins from E. faecalis and E. coli 
suggested that the mutated amino acids are highly con-
served, as shown in Additional file 1: Figure S2a. Expres-
sion of the mutated PDH recued the growth on glucose 
and disruption of E3 encoding gene lpd suspended the 
growth recovery, suggesting the mutated PDH might uti-
lize  NADP+ as redox cofactor. Growth assay on minimal 
glucose medium didn’t show similar results, which might 
be caused by its poor activity (Fig. 2c). However, these E3 
mutations didn’t increase FFA titer, but reduced the titer 
to 439.5 mg/L, comparable with YJZ08 (Additional file 1: 
Figure S2b and Table S1). The FFA results indicated that 
the mutations resulted in enzymatic activity lost, prob-
ably due to unsuccessful protein assembly. To improve 
its enzymatic activity towards  NADP+, rational design 
based on PDH structures or directed evolution will be 
required for further investigation. As E. faecalis PDH 
has been demonstrated to be a functional enzyme in E. 
coli and yeast at both aerobic and anaerobic conditions 
[16, 35], a novel PDH complex with  NADP+ preference 
will clearly be valuable for bioproduction of acetyl-CoA 
derived chemicals.
It was also observed that, PDH expression altered the 
distribution of saturated and unsaturated FFAs (C16 and 
C18) in PDH2, but not in PDH1 (Fig.  2d). The double 
bonds in unsaturated FFAs were formed by Delta-9 fatty 
acid desaturase, encoded by OLE1, through an oxygen-
dependent mechanism that requires reducing equiva-
lents from NADH. Thus, the increase in unsaturated 
FFA ratio might also indicate that the functional PDH 
resulted in cytosolic redox changes without imposing an 
increased NADH burden, due to its insensitive feature to 
high NADH/NAD+ ratios [35–37].
Balance of cytosolic redox factors for FFA production
NAD and NADP redox couples are crucial to maintain 
cellular redox hemostasis, with lower cytosolic NADH/
NAD+ ratios and higher NADPH/NADP+ ratios due to 
their different functions [38]. In FFA production strains, 
over-production of NADH resulted in glycerol accumula-
tion, while NADPH as the cofactor required for fatty acid 
elongation was limited. Thus, the balance between NAD 
and NADP redox couples would be important for FFA 
production.
To balance the redox state of the cell and further 
improve FFA synthesis,  NADP+-dependent glyceralde-
hyde-3-phosphate dehydrogenase (GapN) from Strep-
tococcus mutans [39] was expressed on a multi-copy 
plasmid pGapN in the FFA production strain YJZ08, 
yielding strain ZS02. As shown in Fig.  3, GapN expres-
sion resulted in reduced glycerol accumulation and 
increased FFA production.
We further balanced cytosolic redox conditions 
through interruption of glycerol synthesis via glycerol-
3-phosphate dehydrogenase (GPD) deletions. Since 
GPD1 was regulated by osmotic stress [23], GPD2 was 
first deleted in YJZ08, and the resulting strain ZS03 
showed decreased glycerol accumulation, and increased 
FFA titer and productivity (Fig.  3a). When both GPD1 
and GPD2 were deleted, the specific growth rate of the 
resulted strain ZS04 decreased dramatically, which was 
consistent with previous studies [23]. The final FFA titer 
of ZS03 was 556.0 mg/L, 23.6% higher than YZJ08. When 
GapN was introduced into ZS04, the impaired growth 
was improved, and FFA production at 72 h improved sig-
nificantly. The final FFA titer of ZS05 reached 578.7 mg/L 
at 96 h, which was 28.6% higher than YJZ08 and the pro-
ductivity was comparable with ZS04.
Similarly, the distributions of saturated and unsaturated 
FFA also varied in the constructed strains (Fig. 3b). GPD 
deletion did not alter the distributions, whereas GapN 
expression increased the ratios of saturated FFAs. With 
GapN expressed in YJZ08, the percentage of saturated 
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FFAs increased slightly from 50 to 53%, with the increases 
in the titers of C16:0 and C18:0 but no increases of C16:1 
and C18:1. When GapN expressed in gpd1Δ gpd2Δ 
mutant, in ZS05 the percentage of saturated FFAs further 
increased to 59%, indicating the possible redox changes 
between NAD and NADP redox couples.
Increased provision of acetyl‑CoA and NADPH improved 
FFA production
Plasmid pGapN was transformed into PDH1 and PDH2, 
yielding PDH3 and PDH6, respectively. As shown in 
Fig. 4, the FFA production in PDH3 and PDH6 increased 
to 534.0 and 797.6  mg/L, respectively. Also, glycerol 
accumulation levels in PDH3 and PDH6 reduced to 0.93 
and 0.58 g/L, respectively. The decrease in glycerol level 
and increase in FFA titer in both PDH3 and PDH6 were 
similar with those observed in ZS02.
Similarly, when GPD1 and GPD2 were deleted in PDH1 
and PDH2, the resulting strains PDH4 and PDH7 exhib-
ited decreased growth rates, but increased FFA produc-
tion to 664.0 and 840.5 mg/L, respectively (Fig. 4). Finally, 
when GapN was introduced into PDH4 and PDH7, 
yielding PDH5 and PDH8, the impaired cell growth 
improved, whereas the FFA production decreased to 
614.0 and 715.3 mg/L, respectively (Fig. 4). The improved 
cell growth and decreased FFA titer upon GapN expres-
sion indicated a possible competition for the supply 
of the precursors and redox factors. Previous studies 
with heterologous acetyl-CoA pathways suggested that 
the ACL pathway is promising for production of fatty 
acid and their derivatives [6, 7, 10, 11, 14]. ACL expres-
sion with enhanced fatty acid synthesis resulted in 81% 
higher FFAs than YJZ08 [6, 7], and in this study the titer 
of PDH7 was 83.2% higher compared to YJZ08, similar 
with ACL expression combined with other engineering 
efforts.
Regarding the distribution of saturated and unsatu-
rated FFAs (C16 and C18) of engineered PDH strains, it 
was found that PDH expression significantly increased 
the ratios of unsaturated FFAs (Fig. 5a), even with efforts 
for redox cofactor rebalance. These changes might be 
because of the PDH complex with excess NADH pro-
duced and its consistent activity under high NADH/
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Fig. 3 FFA production with GapN expression and GPD deletions. a FFA production obtained with engineered strains. b Distribution of saturated and 
unsaturated FFAs (C16 and C18) in the engineered strains. Statistical analysis was performed using one-tailed Student’s t test (*p < 0.05, **p < 0.01). 
All data represent the mean ± SD of biological triplicates
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target to increase the unsaturation of the FFAs and their 
derivatives, besides manipulations on Delta-9 fatty acid 
desaturase Ole1 reported to control the fatty acid satura-
tion in previous studies [40, 41].
The intracellular NADH/NAD+ ratios of the engi-
neered PDH strains were lower than that of ZS01 
(Fig. 5b), suggesting the PDH complex alleviated NADH 
burden, as we conferred from cell growth and FFA pro-
duction. GapN expression could further relieve the 
NADH burden, as the NADH/NAD+ ratio of PDH6 and 
PDH8 was lower than that of PDH2, and the ratio of 
PDH8 lower than PDH7.
Conclusions
The expression of the PDH complex from E. faecalis in 
the yeast cytosol enabled efficient acetyl-CoA provision 
with low ATP cost, and improved FFA production in the 
titer, productivity and rate. Rebalancing NAD and NADP 
redox couples further improved FFA production in PDH 
expressing strains. Briefly, the GapN expression seemed 
to increase FFA production via the growth improvement, 
and GPD deletion resulted in dramatically decreased cell 
growth probably due to the high cytosolic NADH bur-
den. The strain PDH7 with PDH expression and GPD 
deletion could achieve a similarly high level of FFA pro-
duction as other best acetyl-CoA producing pathways, 
and could potentially engineered for better performances 
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Fig. 5 Distribution of saturated and unsaturated FFAs (C16 and C18) 
in engineered strains. All data represent the mean ± SD of biological 
triplicates
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metabolism. Moreover, the increase in FFA unsaturation 
in PDH strains suggested that the PDH complex can be 
further engineered for the production of unsaturated 
fatty acids and their derivatives.
Materials and methods
Construction of plasmids and strains
The plasmids, strains, and primers used and constructed 
in this study are listed in Additional file 2: Dataset S1. All 
yeast strains were constructed using GTR-CRISPR sys-
tem as described in [8]. For gene integration and dele-
tion, donor DNA containing 50  bp of homology arms 
and Cas9 plasmid containing gRNA targeting sequence 
were co-transformed using the electroporation method 
as described in [42].
Six genes for PDH pathway from Enterococcus faecalis 
[16] were synthesized by Sangon Company (Shanghai, 
China) and then cloned in pUC57 vectors, yielding plas-
mids pPdhB, pPdhA, pLpd, pAceF, pLplA and pLplA2, 
repectively. lplA and lplA2 were cloned using Golden 
Gate into the vector pAMPori with primers PP1-5, yield-
ing pLplA_A2. These six genes were integrated into two 
sites XI-3 and XII-5 as described in [28]. lplA and lplA2 
were integrated at XI-3 using the Cas9 plasmid pCas9_
XI-3.3 and donor DNA amplified from pLplA_A2 with 
primers PP6 and PP7. pdhB, pdhA, lpd and aceF were 
integrated at the XII-5 site simultaneously using pCas9_
XII-5 and donor DNA amplified from the corresponding 
plasmids with primers PP8-15.
Codon-optimized GapN from Streptococcus mutans 
[39] was synthesized by Sangon Company (Shanghai, 
China) and cloned in pAMPori vector using Golden Gate 
assembly with primers PP16-23, yield pGapN. GapN 
was then integrated into XI-1 using pCas9_XI-1 and 
donor DNA amplified with primers PP24 and PP25 from 
pGapN.
GPD2 was deleted using pCas9_gpd2 and donor DNA 
amplified with primers PP26 and PP27. GPD1 was deleted 
using pCas9_gpd1 and donor DNA amplified with prim-
ers PP28 and PP29. PAH1, DPP1, LPP1 and ARE1 were 
simultaneously deleted using pCas9_PDLA and donor 
DNA fragments with primers PP30-PP37. ZWF1 was 
deleted using pCas9_zwf1 and donor DNA amplified 
with primers PP38 and PP39. ALD6 was deleted using 
pCas9_ald6 and donor DNA amplified with primers PP40 
and PP41. LPD was deleted using pCas9_lpd and donor 
DNA amplified with primer PP42 and PP43.
All Cas9 plasmids containing gRNAs for target genes 
and were constructed using Golden Gate assembly. Take 
pCas9_gpd2 as an example, PCR fragments amplified 
from pScURA with primer PP47, containing 20 bp gRNA 
targeting sequence, were assembled into pCas plasmid 
[8].
Media and cultivation conditions
E. coli strains were cultured at 37 °C in LB medium, com-
posed of 5 g/L yeast extract,10 g/L peptone, and 10 g/L 
NaCl, and 80 mg/mL ampicillin was added when needed.
Yeast strains were cultured either in YPD medium com-
posed of 10 g/L yeast extract, 20 g/L peptone and 20 g/L 
glucose, or SC-URA medium for the selection of strains 
containing URA3-based plasmids, composed of 5  g/L 
 (NH4)2SO4, 1.7  g/L yeast nitrogen base without amino 
acids, 1.914 g/L amino acid mixture without uracil, and 
20  g/L glucose. 5-FOA plates were used to lose URA3-
based plasmid, composed of 1.7 g/L yeast nitrogen base 
without amino acids, 5 g/L  (NH4)2SO4, 1.914 g/L amino 
acid mixture without uracil, 0.05 g/L uracil, 1 g/L 5-FOA, 
25 g/L agar. All solid plates contained 15 g/L agar except 
for 5-FOA plates.
Minimal medium was used for cultivation in shake 
flasks for FFA production, composed of 5 g/L  (NH4)2SO4, 
14.4  g/L  KH2PO4, 0.5  g/L  MgSO4·7H2O, trace metal 
solution and vitamin solution and 20  g/L glucose, and 
40  mg/L histidine or 60  mg/L uracil was added when 
needed. For all PDH strains, minimal medium was sup-
plemented with 100 mg/mL lipoic acid.
Yeast strains were cultured at 30  °C. For shake flask 
cultivation, yeast cells were precultured in falcon tubes 
with 5 mL minimal medium for 24 h, and then inoculated 
into 100 mL shake flasks with 30 mL medium with initial 
 OD600 of 0.1.
Measurement of biomass and extracellular metabolites
Biomass was measured by optical density at 600  nm 
 (OD600) with a GENESYS 30 Visible Spectrophotometer 
(Thermo Electron Scientific, Madison, USA).
Extracellular metabolites including glucose, etha-
nol and glycerol were measured by HPLC (Shimadzu 
LC-20AT, Japan) equipped with RID and UV detectors 
at 210  nm, using 5  mM  H2SO4 as eluent and Aminex 
HPX-87H column (Bio-Rad) at 65 °C with a flow rate of 
0.6 mL/min. The injection volume was 10 μL. A mixture 
composed of 20 g/L glucose, 15 g/L ethanol, 0.5 g/L pyru-
vate, 0.5  g/L succinate, 2  g/L glycerol 2  g/L acetate was 
diluted into 6 gradients with eluent and used as HPLC 
standards.
Extraction, measurement and analysis of FFAs
Total FFAs including extracellular and intracellular 
FFAs were extracted and measured as described in [6]. 
Specifically, 200 μL of cell culture or diluted cell culture 
was transferred into a glass vial, and 10 μL 40% tetrabu-
tylammonium hydroxide and 200  μL methylation rea-
gent was added immediately. Methylation reagent 
contained 200 mM methyl iodide as methyl donor and 
12.5 mg/L pentadecanoic acid as an internal standard. 
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The mixture was shaken for 30  min, and then centri-
fuged at 5000 g for 3 min. 100 μL of dichloromethane 
layer with extracted methyl esters was transferred into 
a GC vial, evaporated 3 h, and resuspended in 100 μL 
hexane. Then samples were analyzed by GC–MS 
(QP2020, Shimadzu, Japan) with a DB-5MS column 
(30  m × 0.250  mm × 0.25  μm, Agilent). The program 
was set as follows: 40 °C 2 min; ramp to 130 °C at 5 °C/
min; raise to 280  °C at 10  °C/min; 280  °C 3  min. The 
temperatures of the inlet, mass transfer line and ion 
source were set at 280, 300, 230  °C, respectively. Flow 
rate of carrier gas was 3.0  mL/min and the injection 
volume was 1  μL. The data were collected in the full 
inspection mode (50–650 m/z), analyzed using GCMS 
solution 4.4 software and quantified with a standard 
curve. The standard curve was calibrated using methyl 
ester standards (F.A.M.E mix, Sigma) for even-chain 
fatty acids (C8-C22) and pentadecanoic acid (C15) with 
6 diluted gradients.
Samples for FFA analysis were harvested at different 
time points due to varied strain growth. The highest 
FFA titers were achieved when ethanol was completely 
consumed. Statistical analysis was performed using 
one-tailed Student’s t test using Microsoft Excel.
Quantification of intracellular NADH/NAD+
Cells were grown to mid-log phase and harvested by 
centrifugation at 11000  g for 1  min. Cell pellets were 
suspended with 400  μL of extraction buffer from the 
NADH/NAD+ Quantitation Kit (Sigma-Aldrich) and 
transferred to a new tube with 50  μL of acid-washed 
glass beads, and kept on dry ice for 10 min. Cells were 
then lysed with a Fastprep homogenizer and imme-
diately put on ice for 2 − 3  min, and centrifuged at 17 
000  g for 10  min. The supernatant was filtered using 
a Pierce protein concentrator (10  K MWCO PES, 
Thermo Scientific) to remove proteins according to the 
kit instruction. All steps between cell harvest and enzy-
matic assay were carried out at 0 °C. NADH and  NAD+ 
were measured following the manufacturer’s instruc-
tion with a micro-plate reader at 450 nm.
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